{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T10:38:28Z","timestamp":1784975908614,"version":"3.55.0"},"reference-count":168,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32270705"],"award-info":[{"award-number":["32270705"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31900490"],"award-info":[{"award-number":["31900490"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,19]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The rising global burden of cancer has driven considerable efforts into the research and development of effective anti-cancer agents. Fortunately, with impressive advances in transcriptome profiling technology, the Connectivity Map (CMap) database has emerged as a promising and powerful drug repurposing approach. It provides an important platform for systematically discovering of the associations among genes, small-molecule compounds and diseases, and elucidating the mechanism of action of drug, contributing toward efficient anti-cancer pharmacotherapy. Moreover, CMap-based computational drug repurposing is gaining attention because of its potential to overcome the bottleneck constraints faced by traditional drug discovery in terms of cost, time and risk. Herein, we provide a comprehensive review of the applications of drug repurposing for anti-cancer drug discovery and summarize approaches for computational drug repurposing. We focus on the principle of the CMap database and novel CMap-based software\/algorithms as well as their progress achieved for drug repurposing in the field of oncotherapy. This article is expected to illuminate the emerging potential of CMap in discovering effective anti-cancer drugs, thereby promoting efficient healthcare for cancer patients.<\/jats:p>","DOI":"10.1093\/bib\/bbad142","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T21:32:11Z","timestamp":1681767131000},"source":"Crossref","is-referenced-by-count":61,"title":["Decoding Connectivity Map-based drug repurposing for oncotherapy"],"prefix":"10.1093","volume":"24","author":[{"given":"Yuanchun","family":"Zhao","sequence":"first","affiliation":[{"name":"School of Chemistry and Life Sciences, Suzhou University of Science and Technology , Suzhou, 215011 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingqi","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Chemistry and Life Sciences, Suzhou University of Science and Technology , Suzhou, 215011 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Chemistry and Life Sciences, Suzhou University of Science and Technology , Suzhou, 215011 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Qi","sequence":"additional","affiliation":[{"name":"School of Chemistry and Life Sciences, Suzhou University of Science and Technology , Suzhou, 215011 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"2023052022214850100_ref1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2023052022214850100_ref2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.tips.2013.06.005","article-title":"Cancer drug discovery by repurposing: teaching new tricks to old dogs","volume":"34","author":"Gupta","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"2023052022214850100_ref3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12859-020-03882-y","article-title":"In silico drug repositioning using deep learning and comprehensive similarity measures","volume":"22","author":"Yi","year":"2021","journal-title":"BMC Bioinformatics"},{"key":"2023052022214850100_ref4","first-page":"651","article-title":"New drugs are not enough-drug repositioning in oncology: an update","volume":"56","author":"Armando","year":"2020","journal-title":"Int J Oncol"},{"key":"2023052022214850100_ref5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/bib\/bbr013","article-title":"Exploiting drug-disease relationships for computational drug repositioning","volume":"12","author":"Dudley","year":"2011","journal-title":"Brief Bioinform"},{"key":"2023052022214850100_ref6","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/bib\/bbz176","article-title":"Biomedical data and computational models for drug repositioning: a comprehensive review","volume":"22","author":"Luo","year":"2021","journal-title":"Brief Bioinform"},{"key":"2023052022214850100_ref7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"2023052022214850100_ref8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40263-013-0128-0","article-title":"Drug repositioning: playing dirty to kill pain","volume":"28","author":"Bastos","year":"2014","journal-title":"CNS Drugs"},{"key":"2023052022214850100_ref9","first-page":"46","article-title":"A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions","volume":"12","author":"Jarada","year":"2020","journal-title":"J Chem"},{"issue":"Suppl 5","key":"2023052022214850100_ref10","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/1752-0509-7-S5-S6","article-title":"Computational drug repositioning through heterogeneous network clustering","volume":"7","author":"Wu","year":"2013","journal-title":"BMC Syst Biol"},{"key":"2023052022214850100_ref11","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/jphp.13273","article-title":"Drug repositioning: a brief overview","volume":"72","author":"Jourdan","year":"2020","journal-title":"J Pharm Pharmacol"},{"key":"2023052022214850100_ref12","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrclinonc.2015.169","article-title":"Drug repurposing in oncology\u2014patient and health systems opportunities","volume":"12","author":"Bertolini","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"2023052022214850100_ref13","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1517\/13543784.15.11.1295","article-title":"Complementary new approaches enable repositioning of failed drug candidates","volume":"15","author":"Tartaglia","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"key":"2023052022214850100_ref14","doi-asserted-by":"crossref","first-page":"654","DOI":"10.7150\/ijbs.9224","article-title":"Recent advances in drug repositioning for the discovery of new anticancer drugs","volume":"10","author":"Shim","year":"2014","journal-title":"Int J Biol Sci"},{"key":"2023052022214850100_ref15","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.628144","article-title":"Drug repurposing strategy (DRS): emerging approach to identify potential therapeutics for treatment of novel coronavirus infection","volume":"8","author":"Sahoo","year":"2021","journal-title":"Front Mol Biosci"},{"key":"2023052022214850100_ref16","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s12272-019-01176-3","article-title":"In silico drug repositioning: from large-scale transcriptome data to therapeutics","volume":"42","author":"Kwon","year":"2019","journal-title":"Arch Pharm Res"},{"key":"2023052022214850100_ref17","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"2023052022214850100_ref18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nrc2044","article-title":"The connectivity map: a new tool for biomedical research","volume":"7","author":"Lamb","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"2023052022214850100_ref19","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.drudis.2012.07.017","article-title":"Applications of connectivity map in drug discovery and development","volume":"17","author":"Qu","year":"2012","journal-title":"Drug Discov Today"},{"key":"2023052022214850100_ref20","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"2023052022214850100_ref21","article-title":"The advantages of connectivity map applied in traditional Chinese medicine","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Pharmacol"},{"key":"2023052022214850100_ref22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ygyno.2010.10.003","article-title":"A gene signature-based approach identifies thioridazine as an inhibitor of phosphatidylinositol-3\u2032-kinase (PI3K)\/AKT pathway in ovarian cancer cells","volume":"120","author":"Rho","year":"2011","journal-title":"Gynecol Oncol"},{"key":"2023052022214850100_ref23","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.7150\/ijbs.24612","article-title":"Review of drug repositioning approaches and resources","volume":"14","author":"Xue","year":"2018","journal-title":"Int J Biol Sci"},{"key":"2023052022214850100_ref24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.semcancer.2019.09.020","article-title":"Systems biology based drug repositioning for development of cancer therapy","volume":"68","author":"Turanli","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"2023052022214850100_ref25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.12793\/tcp.2019.27.2.59","article-title":"A review of computational drug repurposing","volume":"27","author":"Park","year":"2019","journal-title":"Transl Clin Pharmacol"},{"key":"2023052022214850100_ref26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.compbiomed.2019.05.006","article-title":"DrugR+: a comprehensive relational database for drug repurposing, combination therapy, and replacement therapy","volume":"109","author":"Masoudi-Sobhanzadeh","year":"2019","journal-title":"Comput Biol Med"},{"key":"2023052022214850100_ref27","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/bib\/bbx017","article-title":"A review of network-based approaches to drug repositioning","volume":"19","author":"Lotfi Shahreza","year":"2018","journal-title":"Brief Bioinform"},{"key":"2023052022214850100_ref28","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.3389\/fonc.2020.01786","article-title":"The oncolytic virus in cancer diagnosis and treatment","volume":"10","author":"Cao","year":"2020","journal-title":"Front Oncol"},{"key":"2023052022214850100_ref29","article-title":"Thioguanine induces apoptosis in triple-negative breast cancer by regulating PI3K-AKT pathway","volume":"10","author":"Zhang","year":"2020","journal-title":"Front Oncol"},{"key":"2023052022214850100_ref30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbrc.2022.03.026","article-title":"From DNMT1 degrader to ferroptosis promoter: drug repositioning of 6-thioguanine as a ferroptosis inducer in gastric cancer","volume":"603","author":"Zhang","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"2023052022214850100_ref31","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/1878-0261.12364","article-title":"A drug-repositioning screen for primary pancreatic ductal adenocarcinoma cells identifies 6-thioguanine as an effective therapeutic agent for TPMT-low cancer cells","volume":"12","author":"Kim","year":"2018","journal-title":"Mol Oncol"},{"key":"2023052022214850100_ref32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.canlet.2019.10.034","article-title":"Imatinib revives the therapeutic potential of metformin on Ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways","volume":"469","author":"Nan","year":"2020","journal-title":"Cancer Lett"},{"issue":"Suppl 1","key":"2023052022214850100_ref33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0001-7310(07)70179-5","article-title":"Topical antimicrobial agents in dermatology","volume":"98","author":"Porras-Luque","year":"2007","journal-title":"Actas Dermosifiliogr"},{"key":"2023052022214850100_ref34","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3892\/ol.2017.6325","article-title":"Repurposing itraconazole as an anticancer agent","volume":"14","author":"Tsubamoto","year":"2017","journal-title":"Oncol Lett"},{"key":"2023052022214850100_ref35","doi-asserted-by":"crossref","first-page":"28510","DOI":"10.18632\/oncotarget.15324","article-title":"Itraconazole exerts its anti-melanoma effect by suppressing hedgehog, Wnt, and PI3K\/mTOR signaling pathways","volume":"8","author":"Liang","year":"2017","journal-title":"Oncotarget"},{"key":"2023052022214850100_ref36","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110661","article-title":"Itraconazole exerts anti-liver cancer potential through the Wnt, PI3K\/AKT\/mTOR, and ROS pathways","volume":"131","author":"Wang","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"2023052022214850100_ref37","first-page":"3521","article-title":"Itraconazole modulates hedgehog, WNT\/\u03b2-catenin, as well as Akt signalling, and inhibits proliferation of cervical cancer cells","volume":"37","author":"Ueda","year":"2017","journal-title":"Anticancer Res"},{"key":"2023052022214850100_ref38","doi-asserted-by":"crossref","first-page":"515","DOI":"10.21873\/anticanres.11343","article-title":"Itraconazole inhibits AKT\/mTOR Signaling and proliferation in endometrial cancer cells","volume":"37","author":"Tsubamoto","year":"2017","journal-title":"Anticancer Res"},{"key":"2023052022214850100_ref39","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.4161\/auto.28912","article-title":"Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking","volume":"10","author":"Liu","year":"2014","journal-title":"Autophagy"},{"key":"2023052022214850100_ref40","doi-asserted-by":"crossref","first-page":"20253","DOI":"10.1038\/srep20253","article-title":"Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanoma","volume":"6","author":"Zhu","year":"2016","journal-title":"Sci Rep"},{"key":"2023052022214850100_ref41","first-page":"48","article-title":"Effect of Nifuroxazide on proliferation, migration, and invasion of thyroid papillary carcinoma cells","volume":"50","author":"Hu","year":"2019","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"2023052022214850100_ref42","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.canlet.2021.12.014","article-title":"Drug repositioning: using psychotropic drugs for the treatment of glioma","volume":"527","author":"You","year":"2022","journal-title":"Cancer Lett"},{"key":"2023052022214850100_ref43","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13046-020-1534-z","article-title":"Repurposing chlorpromazine in the treatment of glioblastoma multiforme: analysis of literature and forthcoming steps","volume":"39","author":"Abbruzzese","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"2023052022214850100_ref44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114403","article-title":"Chlorpromazine, an antipsychotic agent, induces G2\/M phase arrest and apoptosis via regulation of the PI3K\/AKT\/mTOR-mediated autophagy pathways in human oral cancer","volume":"184","author":"Jhou","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"2023052022214850100_ref45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00280-021-04386-z","article-title":"Repurposed antipsychotic chlorpromazine inhibits colorectal cancer and pulmonary metastasis by inducing G2\/M cell cycle arrest, apoptosis, and autophagy","volume":"89","author":"Xu","year":"2022","journal-title":"Cancer Chemother Pharmacol"},{"key":"2023052022214850100_ref46","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1158\/0008-5472.CAN-07-2235","article-title":"The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action","volume":"67","author":"Lee","year":"2007","journal-title":"Cancer Res"},{"key":"2023052022214850100_ref47","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/aam.aam_56_18","article-title":"Inflammation and cancer","volume":"18","author":"Singh","year":"2019","journal-title":"Ann Afr Med"},{"key":"2023052022214850100_ref48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072605","article-title":"Anti-inflammatory drugs as anticancer agents","volume":"21","author":"Zappavigna","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2023052022214850100_ref49","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/carcin\/bgh345","article-title":"Activation of the caspase-8\/bid and Bax pathways in aspirin-induced apoptosis in gastric cancer","volume":"26","author":"Gu","year":"2005","journal-title":"Carcinogenesis"},{"key":"2023052022214850100_ref50","doi-asserted-by":"crossref","first-page":"175883592094797","DOI":"10.1177\/1758835920947976","article-title":"Aspirin potentiates celecoxib-induced growth inhibition and apoptosis in human non-small cell lung cancer by targeting GRP78 activity","volume":"12","author":"Zhang","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"2023052022214850100_ref51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cellsig.2017.04.001","article-title":"Niclosamide: beyond an antihelminthic drug","volume":"41","author":"Chen","year":"2018","journal-title":"Cell Signal"},{"key":"2023052022214850100_ref52","doi-asserted-by":"crossref","first-page":"9825","DOI":"10.1007\/s13277-015-4650-1","article-title":"Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer","volume":"37","author":"Liu","year":"2016","journal-title":"Tumour Biol"},{"key":"2023052022214850100_ref53","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bcp.2017.08.009","article-title":"Antihelminthic drug niclosamide inhibits CIP2A and reactivates tumor suppressor protein phosphatase 2A in non-small cell lung cancer cells","volume":"144","author":"Kim","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"2023052022214850100_ref54","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/bib\/bbv020","article-title":"A survey of current trends in computational drug repositioning","volume":"17","author":"Li","year":"2016","journal-title":"Brief Bioinform"},{"key":"2023052022214850100_ref55","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/cas.14318","article-title":"Drug repositioning in cancer: the current situation in Japan","volume":"111","author":"Masuda","year":"2020","journal-title":"Cancer Sci"},{"key":"2023052022214850100_ref56","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.drudis.2018.05.010","article-title":"Machine learning in chemoinformatics and drug discovery","volume":"23","author":"Lo","year":"2018","journal-title":"Drug Discov Today"},{"key":"2023052022214850100_ref57","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.tips.2019.06.004","article-title":"Advancing drug discovery via artificial intelligence","volume":"40","author":"Chan","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"2023052022214850100_ref58","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1021\/jm020491t","article-title":"Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates","volume":"46","author":"Shen","year":"2003","journal-title":"J Med Chem"},{"key":"2023052022214850100_ref59","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1517\/17460441.2014.866943","article-title":"Support vector machines for drug discovery","volume":"9","author":"Heikamp","year":"2014","journal-title":"Expert Opin Drug Discov"},{"key":"2023052022214850100_ref60","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1021\/ci030283p","article-title":"Use of robust classification techniques for the prediction of human cytochrome P450 2D6 inhibition","volume":"43","author":"Susnow","year":"2003","journal-title":"J Chem Inf Comput Sci"},{"key":"2023052022214850100_ref61","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.drudis.2018.01.039","article-title":"The rise of deep learning in drug discovery","volume":"23","author":"Chen","year":"2018","journal-title":"Drug Discov Today"},{"key":"2023052022214850100_ref62","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/msb.2011.26","article-title":"PREDICT: a method for inferring novel drug indications with application to personalized medicine","volume":"7","author":"Gottlieb","year":"2011","journal-title":"Mol Syst Biol"},{"key":"2023052022214850100_ref63","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1093\/bioinformatics\/btv055","article-title":"Similarity-based prediction for anatomical therapeutic chemical classification of drugs by integrating multiple data sources","volume":"31","author":"Liu","year":"2015","journal-title":"Bioinformatics"},{"key":"2023052022214850100_ref64","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"2023052022214850100_ref65","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13073-021-00968-x","article-title":"Deep learning in cancer diagnosis, prognosis and treatment selection","volume":"13","author":"Tran","year":"2021","journal-title":"Genome Med"},{"key":"2023052022214850100_ref66","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature14539","article-title":"Deep learning","volume":"521","author":"LeCun","year":"2015","journal-title":"Nature"},{"key":"2023052022214850100_ref67","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/acscentsci.7b00512","article-title":"Generating focused molecule libraries for drug discovery with recurrent neural networks","volume":"4","author":"Segler","year":"2018","journal-title":"ACS Cent Sci"},{"key":"2023052022214850100_ref68","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.semcancer.2019.12.011","article-title":"Machine and deep learning approaches for cancer drug repurposing","volume":"68","author":"Issa","year":"2021","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"2023052022214850100_ref69","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa357","article-title":"Topological network measures for drug repositioning","volume":"22","author":"Badkas","year":"2021","journal-title":"Brief Bioinform"},{"key":"2023052022214850100_ref70","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1109\/TCBB.2014.2325031","article-title":"Network-based drug-target interaction prediction with probabilistic soft logic","volume":"11","author":"Fakhraei","year":"2014","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"key":"2023052022214850100_ref71","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/cvr\/cvs289","article-title":"Drug interaction networks: an introduction to translational and clinical applications","volume":"97","author":"Azuaje","year":"2013","journal-title":"Cardiovasc Res"},{"key":"2023052022214850100_ref72","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41467-017-00680-8","article-title":"A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information","volume":"8","author":"Luo","year":"2017","journal-title":"Nat Commun"},{"key":"2023052022214850100_ref73","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.semcancer.2020.01.008","article-title":"Repurposing drugs in oncology: from candidate selection to clinical adoption","volume":"68","author":"Pantziarka","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"2023052022214850100_ref74","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/bib\/bbr005","article-title":"Literature mining, ontologies and information visualization for drug repurposing","volume":"12","author":"Andronis","year":"2011","journal-title":"Brief Bioinform"},{"key":"2023052022214850100_ref75","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/jamia\/ocw142","article-title":"MeSHDD: literature-based drug-drug similarity for drug repositioning","volume":"24","author":"Brown","year":"2017","journal-title":"J Am Med Inform Assoc"},{"key":"2023052022214850100_ref76","first-page":"172","article-title":"Exploring the pharmacogenomics knowledge base (PharmGKB) for repositioning breast cancer drugs by leveraging web ontology language (OWL) and cheminformatics approaches","author":"Zhu","year":"2014","journal-title":"Pac Symp Biocomput"},{"key":"2023052022214850100_ref77","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.drudis.2013.11.005","article-title":"Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines","volume":"19","author":"Jin","year":"2014","journal-title":"Drug Discov Today"},{"key":"2023052022214850100_ref78","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.drudis.2012.07.014","article-title":"Transcriptional data: a new gateway to drug repositioning?","volume":"18","author":"Iorio","year":"2013","journal-title":"Drug Discov Today"},{"key":"2023052022214850100_ref79","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/PPO.0000000000000370","article-title":"Transcriptome signature reversion as a method to reposition drugs against cancer for precision oncology","volume":"25","author":"Koudjis","year":"2019","journal-title":"Cancer J"},{"key":"2023052022214850100_ref80","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.prp.2018.09.013","article-title":"Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and connectivity map database","volume":"214","author":"Luo","year":"2018","journal-title":"Pathol Res Pract"},{"key":"2023052022214850100_ref81","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene Set Enrichment Analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023052022214850100_ref82","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nbt.3183","article-title":"Opportunities for drug repositioning from phenome-wide association studies","volume":"33","author":"Rastegar-Mojarad","year":"2015","journal-title":"Nat Biotechnol"},{"key":"2023052022214850100_ref83","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.drudis.2022.03.006","article-title":"Structure-based drug repurposing: traditional and advanced AI\/ML-aided methods","volume":"27","author":"Choudhury","year":"2022","journal-title":"Drug Discov Today"},{"key":"2023052022214850100_ref84","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/bib\/bbaa288","article-title":"A review on drug repurposing applicable to COVID-19","volume":"22","author":"Dotolo","year":"2021","journal-title":"Brief Bioinform"},{"key":"2023052022214850100_ref85","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","article-title":"Docking and scoring in virtual screening for drug discovery: methods and applications","volume":"3","author":"Kitchen","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"2023052022214850100_ref86","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"2023052022214850100_ref87","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"2023052022214850100_ref88","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J Mol Biol"},{"key":"2023052022214850100_ref89","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8","article-title":"Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking","volume":"37","author":"Kramer","year":"1999","journal-title":"Proteins"},{"key":"2023052022214850100_ref90","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1021\/jm020406h","article-title":"Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine","volume":"46","author":"Jain","year":"2003","journal-title":"J Med Chem"},{"key":"2023052022214850100_ref91","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/jcc.10306","article-title":"Detailed analysis of grid-based molecular docking: a case study of CDOCKER-A CHARMm-based MD docking algorithm","volume":"24","author":"Wu","year":"2003","journal-title":"J Comput Chem"},{"key":"2023052022214850100_ref92","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J Med Chem"},{"key":"2023052022214850100_ref93","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/med.20067","article-title":"Combining docking and molecular dynamic simulations in drug design","volume":"26","author":"Alonso","year":"2006","journal-title":"Med Res Rev"},{"key":"2023052022214850100_ref94","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119105","article-title":"Network pharmacology and molecular docking reveal the mechanism of Scopoletin against non-small cell lung cancer","volume":"270","author":"Yuan","year":"2021","journal-title":"Life Sci"},{"key":"2023052022214850100_ref95","doi-asserted-by":"crossref","first-page":"315","DOI":"10.34172\/bi.2021.40","article-title":"A fuzzy logic-based computational method for the repurposing of drugs against COVID-19","volume":"12","author":"Masoudi-Sobhanzadeh","year":"2022","journal-title":"Bioimpacts"},{"key":"2023052022214850100_ref96","doi-asserted-by":"crossref","first-page":"368504221109215","DOI":"10.1177\/00368504221109215","article-title":"Integration of various protein similarities using random forest technique to infer augmented drug-protein matrix for enhancing drug-disease association prediction","volume":"105","author":"Kitsiranuwat","year":"2022","journal-title":"Sci Prog"},{"key":"2023052022214850100_ref97","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cmpb.2018.04.013","article-title":"Diseases diagnosis using fuzzy logic methods: a systematic and meta-analysis review","volume":"161","author":"Ahmadi","year":"2018","journal-title":"Comput Methods Programs Biomed"},{"key":"2023052022214850100_ref98","doi-asserted-by":"crossref","first-page":"91908","DOI":"10.1155\/JBB\/2006\/91908","article-title":"Fuzzy logic in medicine and bioinformatics","volume":"2006","author":"Torres","year":"2006","journal-title":"J Biomed Biotechnol"},{"key":"2023052022214850100_ref99","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41398-021-01724-w","article-title":"Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example","volume":"11","author":"Imami","year":"2021","journal-title":"Transl Psychiatry"},{"key":"2023052022214850100_ref100","first-page":"506","article-title":"A review of connectivity map and computational approaches in pharmacogenomics","volume":"19","author":"Musa","year":"2018","journal-title":"Brief Bioinform"},{"key":"2023052022214850100_ref101","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ccr.2006.09.005","article-title":"Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators","volume":"10","author":"Hieronymus","year":"2006","journal-title":"Cancer Cell"},{"key":"2023052022214850100_ref102","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1039\/D1CB00069A","article-title":"Computational analyses of mechanism of action (MoA): data, methods and integration","volume":"3","author":"Trapotsi","year":"2022","journal-title":"RSC Chem Biol"},{"key":"2023052022214850100_ref103","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.tox.2009.09.014","article-title":"Application of connectivity mapping in predictive toxicology based on gene-expression similarity","volume":"268","author":"Smalley","year":"2010","journal-title":"Toxicology"},{"key":"2023052022214850100_ref104","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7554\/eLife.71880","article-title":"A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer","volume":"11","author":"Yang","year":"2022","journal-title":"Elife"},{"key":"2023052022214850100_ref105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-021-02903-5","article-title":"Identification of circRNA\u2013miRNA\u2013mRNA networks contributes to explore underlying pathogenesis and therapy strategy of gastric cancer","volume":"19","author":"Dong","year":"2021","journal-title":"J Transl Med"},{"key":"2023052022214850100_ref106","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.apsb.2021.12.005","article-title":"Identification of anthelmintic parbendazole as a therapeutic molecule for HNSCC through connectivity map-based drug repositioning","volume":"12","author":"Liang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"2023052022214850100_ref107","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1715","article-title":"Querying genomic databases: refining the connectivity map","volume":"11","author":"Segal","year":"2012","journal-title":"Stat Appl Genet Mol Biol"},{"key":"2023052022214850100_ref108","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1674-6384(16)60019-9","article-title":"Application of connectivity map database to research on Chinese Materia Medica","volume":"8","author":"Lv","year":"2016","journal-title":"Chin Herb Med"},{"key":"2023052022214850100_ref109","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120267","article-title":"Potential role of drug repositioning strategy (DRS) for management of tauopathy","volume":"291","author":"Zaki","year":"2022","journal-title":"Life Sci"},{"key":"2023052022214850100_ref110","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/s12859-019-3028-6","article-title":"Influence of batch effect correction methods on drug induced differential gene expression profiles","volume":"20","author":"Zhou","year":"2019","journal-title":"BMC Bioinformatics"},{"key":"2023052022214850100_ref111","doi-asserted-by":"crossref","first-page":"17624","DOI":"10.1038\/s41598-021-97005-z","article-title":"Evaluation of connectivity map shows limited reproducibility in drug repositioning","volume":"11","author":"Lim","year":"2021","journal-title":"Sci Rep"},{"key":"2023052022214850100_ref112","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225601","article-title":"Cellular stress-modulating drugs can potentially be identified by in silico screening with connectivity map (CMap)","volume":"20","author":"Gao","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2023052022214850100_ref113","doi-asserted-by":"crossref","DOI":"10.1038\/npjsba.2016.15","article-title":"L1000CDS(2): LINCS L1000 characteristic direction signatures search engine","volume":"2","author":"Duan","year":"2016","journal-title":"NPJ Syst Biol Appl"},{"key":"2023052022214850100_ref114","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gku476","article-title":"LINCS canvas browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures","volume":"42","author":"Duan","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2023052022214850100_ref115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004068","article-title":"Prioritizing therapeutics for lung cancer: an integrative meta-analysis of cancer gene signatures and chemogenomic data","volume":"11","author":"Fortney","year":"2015","journal-title":"PLoS Comput Biol"},{"issue":"Suppl 13","key":"2023052022214850100_ref116","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1471-2105-16-S13-S4","article-title":"DMAP: a connectivity map database to enable identification of novel drug repositioning candidates","volume":"16","author":"Huang","year":"2015","journal-title":"BMC Bioinformatics"},{"key":"2023052022214850100_ref117","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.biopha.2018.11.127","article-title":"An update on drug repurposing: re-written saga of the drug\u2019s fate","volume":"110","author":"Gns","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"2023052022214850100_ref118","article-title":"Functional module connectivity map (FMCM): a framework for searching repurposed drug compounds for systems treatment of cancer and an application to colorectal adenocarcinoma","volume":"9","author":"Chung","year":"2014","journal-title":"PloS One"},{"key":"2023052022214850100_ref119","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcancer.2019.12.012","article-title":"Drug repurposing for cancer therapy, easier said than done","volume":"68","author":"Gonzalez-Fierro","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"2023052022214850100_ref120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/1471-2105-10-236","article-title":"sscMap: an extensible java application for connecting small-molecule drugs using gene-expression signatures","volume":"10","author":"Zhang","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"2023052022214850100_ref121","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/stem.1398","article-title":"Entinostat prevents leukemia maintenance in a collaborating oncogene-dependent model of cytogenetically normal acute myeloid leukemia","volume":"31","author":"Ramsey","year":"2013","journal-title":"Stem Cells"},{"key":"2023052022214850100_ref122","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1038\/s41598-017-06897-3","article-title":"The LncRNA connectivity map: using LncRNA signatures to connect small molecules, LncRNAs, and diseases","volume":"7","author":"Yang","year":"2017","journal-title":"Sci Rep"},{"key":"2023052022214850100_ref123","doi-asserted-by":"crossref","first-page":"12428","DOI":"10.18632\/aging.102581","article-title":"System level characterization of small molecule drugs and their affected long noncoding RNAs","volume":"11","author":"Yang","year":"2019","journal-title":"Aging"},{"key":"2023052022214850100_ref124","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12911-021-01617-4","article-title":"Clinical connectivity map for drug repurposing: using laboratory results to bridge drugs and diseases","volume":"21","author":"Wen","year":"2021","journal-title":"BMC Med Inform Decis Mak"},{"key":"2023052022214850100_ref125","doi-asserted-by":"crossref","first-page":"1801039","DOI":"10.1002\/advs.201801039","article-title":"Engineering precision medicine","volume":"6","author":"Sun","year":"2019","journal-title":"Adv Sci"},{"key":"2023052022214850100_ref126","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194781","article-title":"The need for multi-omics biomarker signatures in precision medicine","volume":"20","author":"Olivier","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2023052022214850100_ref127","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","author":"Collins","year":"2015","journal-title":"N Engl J Med"},{"key":"2023052022214850100_ref128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008696","article-title":"Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways","volume":"17","author":"Yu","year":"2021","journal-title":"PLoS Comput Biol"},{"key":"2023052022214850100_ref129","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.625991","article-title":"Computational drug repositioning and experimental validation of Ivermectin in treatment of gastric cancer","volume":"12","author":"Rabben","year":"2021","journal-title":"Front Pharmacol"},{"key":"2023052022214850100_ref130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbrc.2017.04.157","article-title":"Identification of repaglinide as a therapeutic drug for glioblastoma multiforme","volume":"488","author":"Xiao","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"2023052022214850100_ref131","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.665276","article-title":"Identification of prognostic signature and gliclazide as candidate drugs in lung adenocarcinoma","volume":"11","author":"Cheng","year":"2021","journal-title":"Front Oncol"},{"key":"2023052022214850100_ref132","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.745590","article-title":"Identification of novel drug candidate for epithelial ovarian cancer via in silico investigation and in vitro validation","volume":"11","author":"Zou","year":"2021","journal-title":"Front Oncol"},{"key":"2023052022214850100_ref133","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1158\/1535-7163.MCT-13-0750","article-title":"Computational repositioning and preclinical validation of pentamidine for renal cell cancer","volume":"13","author":"Zerbini","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"2023052022214850100_ref134","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1289\/ehp.929813","article-title":"Role of proto-oncogene activation in carcinogenesis","volume":"98","author":"Anderson","year":"1992","journal-title":"Environ Health Perspect"},{"key":"2023052022214850100_ref135","doi-asserted-by":"crossref","first-page":"75425","DOI":"10.18632\/oncotarget.12251","article-title":"Targeting SALL4 by entinostat in lung cancer","volume":"7","author":"Yong","year":"2016","journal-title":"Oncotarget"},{"key":"2023052022214850100_ref136","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1038\/onc.2013.495","article-title":"SALL4, a novel marker for human gastric carcinogenesis and metastasis","volume":"33","author":"Zhang","year":"2014","journal-title":"Oncogene"},{"key":"2023052022214850100_ref137","first-page":"1171","article-title":"Oncofetal gene SALL4 in aggressive hepatocellular carcinoma","volume":"369","author":"Masuda","year":"2013","journal-title":"N Engl J Med"},{"key":"2023052022214850100_ref138","first-page":"536","article-title":"Identification of phenothiazine as an ETV1-targeting agent in gastrointestinal stromal tumors using the connectivity map","volume":"55","author":"Yen","year":"2019","journal-title":"Int J Oncol"},{"key":"2023052022214850100_ref139","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.18632\/oncotarget.26725","article-title":"AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple-negative breast cancer","volume":"10","author":"Goyette","year":"2019","journal-title":"Oncotarget"},{"key":"2023052022214850100_ref140","doi-asserted-by":"crossref","first-page":"10567","DOI":"10.1021\/acsami.7b01938","article-title":"Precise engineering of prodrug cocktails into single polymeric nanoparticles for combination cancer therapy: extended and sequentially controllable drug release","volume":"9","author":"Wang","year":"2017","journal-title":"ACS Appl Mater Interfaces"},{"key":"2023052022214850100_ref141","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.drudis.2016.05.015","article-title":"Drug combination therapy increases successful drug repositioning","volume":"21","author":"Sun","year":"2016","journal-title":"Drug Discov Today"},{"key":"2023052022214850100_ref142","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.tips.2005.02.007","article-title":"The efficiency of multi-target drugs: the network approach might help drug design","volume":"26","author":"Csermely","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"2023052022214850100_ref143","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105007","article-title":"Lymecycline reverses acquired EGFR-TKI resistance in non-small-cell lung cancer by targeting GRB2","volume":"159","author":"Chen","year":"2020","journal-title":"Pharmacol Res"},{"key":"2023052022214850100_ref144","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41391-021-00426-0","article-title":"Discovery of a new candidate drug to overcome cabazitaxel-resistant gene signature in castration-resistant prostate cancer by in silico screening","volume":"26","author":"Hongo","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2023052022214850100_ref145","article-title":"Predicting agents that can overcome 5-FU resistance in colorectal cancers via pharmacogenomic analysis","volume":"9","author":"Huang","year":"2021","journal-title":"Biomedicine"},{"key":"2023052022214850100_ref146","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1186\/s12885-021-09048-0","article-title":"Transcription factor network analysis based on single cell RNA-seq identifies that Trichostatin-a reverses docetaxel resistance in prostate cancer","volume":"21","author":"Schnepp","year":"2021","journal-title":"BMC Cancer"},{"key":"2023052022214850100_ref147","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1016\/j.devcel.2021.09.023","article-title":"CLIP-170S is a microtubule +TIP variant that confers resistance to taxanes by impairing drug-target engagement","volume":"56","author":"Thakkar","year":"2021","journal-title":"Dev Cell"},{"key":"2023052022214850100_ref148","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/ijc.31912","article-title":"Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide","volume":"144","author":"Johannessen","year":"2019","journal-title":"Int J Cancer"},{"key":"2023052022214850100_ref149","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1164\/rccm.201207-1180OC","article-title":"Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer","volume":"186","author":"Yeh","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2023052022214850100_ref150","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12859-020-03644-w","article-title":"Synthetic repurposing of drugs against hypertension: a datamining method based on association rules and a novel discrete algorithm","volume":"21","author":"Masoudi-Sobhanzadeh","year":"2020","journal-title":"BMC Bioinformatics"},{"key":"2023052022214850100_ref151","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.csbj.2021.01.046","article-title":"Identification and validation of a prognostic signature and combination drug therapy for immunotherapy of head and neck squamous cell carcinoma","volume":"19","author":"Qiang","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"2023052022214850100_ref152","first-page":"43","article-title":"MEK inhibitors and their potential in the treatment of advanced melanoma: the advantages of combination therapy","volume":"10","author":"Tran","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"2023052022214850100_ref153","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.181321","article-title":"Systematic polypharmacology and drug repurposing via an integrated L1000-based connectivity map database mining","volume":"5","author":"Liu","year":"2018","journal-title":"R Soc Open Sci"},{"key":"2023052022214850100_ref154","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170551","article-title":"Cudraflavone C induces tumor-specific apoptosis in colorectal cancer cells through inhibition of the phosphoinositide 3-kinase (PI3K)-AKT pathway","volume":"12","author":"Soo","year":"2017","journal-title":"PloS One"},{"key":"2023052022214850100_ref155","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1002\/jcp.30120","article-title":"Target identification of a novel unsymmetrical 1,3,4-oxadiazole derivative with antiproliferative properties","volume":"236","author":"Weidong","year":"2021","journal-title":"J Cell Physiol"},{"issue":"6","key":"2023052022214850100_ref156","doi-asserted-by":"crossref","DOI":"10.3390\/nu11061397","article-title":"Using the pleiotropic characteristics of curcumin to validate the potential application of a novel gene expression screening platform","volume":"11","author":"Liao","year":"2019","journal-title":"Nutrients"},{"key":"2023052022214850100_ref157","doi-asserted-by":"crossref","first-page":"86168","DOI":"10.18632\/oncotarget.21030","article-title":"In silico and in vitro identification of inhibitory activities of sorafenib on histone deacetylases in hepatocellular carcinoma cells","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"2023052022214850100_ref158","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1186\/s12864-015-1918-1","article-title":"Helveticoside is a biologically active component of the seed extract of Descurainia sophia and induces reciprocal gene regulation in A549 human lung cancer cells","volume":"16","author":"Kim","year":"2015","journal-title":"BMC Genomics"},{"key":"2023052022214850100_ref159","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2013.04.014","article-title":"6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor \u03b3 (PPAR\u03b3)","volume":"336","author":"Tan","year":"2013","journal-title":"Cancer Lett"},{"key":"2023052022214850100_ref160","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.prp.2018.03.029","article-title":"In silico analysis of the potential mechanism of telocinobufagin on breast cancer MCF-7 cells","volume":"214","author":"Dang","year":"2018","journal-title":"Pathol Res Pract"},{"key":"2023052022214850100_ref161","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/clpt.2013.1","article-title":"Computational drug repositioning: from data to therapeutics","volume":"93","author":"Hurle","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"2023052022214850100_ref162","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.tibtech.2017.02.012","article-title":"Why batch effects matter in omics data, and how to avoid them","volume":"35","author":"Goh","year":"2017","journal-title":"Trends Biotechnol"},{"key":"2023052022214850100_ref163","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2105-15-113","article-title":"Probabilistic drug connectivity mapping","volume":"15","author":"Parkkinen","year":"2014","journal-title":"BMC Bioinformatics"},{"key":"2023052022214850100_ref164","first-page":"5","article-title":"Evaluation of analytical methods for connectivity map data","author":"Cheng","year":"2013","journal-title":"Pac Symp Biocomput"},{"key":"2023052022214850100_ref165","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s13073-014-0095-1","article-title":"Systematic evaluation of connectivity map for disease indications","volume":"6","author":"Cheng","year":"2014","journal-title":"Genome Med"},{"key":"2023052022214850100_ref166","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.molcel.2016.12.005","article-title":"A strategy to combine sample multiplexing with targeted proteomics assays for high-throughput protein signature characterization","volume":"65","author":"Erickson","year":"2017","journal-title":"Mol Cell"},{"key":"2023052022214850100_ref167","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.cels.2018.03.012","article-title":"A library of phosphoproteomic and chromatin signatures for characterizing cellular responses to drug perturbations","volume":"6","author":"Litichevskiy","year":"2018","journal-title":"Cell Syst"},{"key":"2023052022214850100_ref168","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1021\/acschembio.9b00694","article-title":"A proteomic connectivity map for characterizing the tumor adaptive response to small molecule chemical Perturbagens","volume":"15","author":"Zi","year":"2020","journal-title":"ACS Chem Biol"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/24\/3\/bbad142\/50411054\/bbad142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/24\/3\/bbad142\/50411054\/bbad142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T11:33:07Z","timestamp":1702121587000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbad142\/7126345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":168,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5,19]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbad142","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,5]]},"published":{"date-parts":[[2023,4,17]]},"article-number":"bbad142"}}